(Hypertension. 1999;34:643-648.)
© 1999 American Heart Association, Inc.
Scientific Contributions |
From the Max-Delbrück-Center for Molecular Medicine (N.H., Y-A.L., K.L., D.G.), and the Department of Clinical Pharmacology (N.H., D.G., R.K.) and Department of Medicine IV (R.K.), Benjamin Franklin Medical Center, Freie Universität Berlin, Berlin, Germany; the Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School (K.L.), Boston, Mass; and the Pharmaceuticals Division of F. Hoffmann-La Roche (K.L.), Basel, Switzerland.
Correspondence to Dr Reinhold Kreutz, Department of Clinical Pharmacology, Benjamin Franklin Medical Center, Freie Universität Berlin, Hindenburgdamm 30, 12200 Berlin, Germany. E-mail Kreutz{at}medizin.fu-berlin.de
| Abstract |
|---|
|
|
|---|
Key Words: hypertension, essential rats, inbred SHR rats, inbred WKY genetics complex traits crosses, genetic
| Introduction |
|---|
|
|
|---|
The identification of the Sa gene by Iwai and Inagami3 and the observation of its differential expression pattern in kidneys from hypertensive and normotensive rat models has generated considerable interest over the past few years.4 Subsequent to its identification, several investigators have shown that the Sa gene locus cosegregates with blood pressure and is localized within a major blood pressure quantitative trait locus (QTL) on rat chromosome 1 (Chr 1).5 6 7 8 9 10 11 12 Furthermore, cosegregation of an Sa gene polymorphism and differential Sa gene expression was demonstrated.7 The Sa gene therefore represents an attractive candidate to explain the effect of the Chr 1 QTL on blood pressure. Congenic experimentation recently lead to the verification of the Chr 1 blood pressure QTL spanning the Sa locus.13 14 15
Despite successful QTL detection and isolation of a large congenic region around the Sa gene locus, only fine mapping of the QTL to a small chromosomal fragment will ultimately facilitate positional cloning or positional candidate gene identification. The basis of single QTLoriented fine mapping is similar to that of Mendelian-gene fine mapping, that is, analysis of recombinants within a congenic interval previously found to account for the phenotypic variation.
The current set of experiments was aimed to evaluate whether the Sa gene explains the effect of the Chr 1 QTL on blood pressure by congenic substitution mapping approaches. Congenic strains were developed by introgressing high blood pressure QTL alleles from the stroke-prone spontaneously hypertensive rat (SHRSP) into the normotensive Wistar-Kyoto (WKY-1) reference strain. Blood pressures in congenic animals were determined by radiotelemetry at baseline and after dietary sodium loading. Our current results provide definitive evidence that the Sa gene cannot be considered a candidate within the investigated QTL on Chr 1. This would currently allow the localization of the Chr 1 blood pressure QTL centromerically to the Sa gene locus, possibly, as recently suggested,16 guiding the genetic analysis for human essential hypertension.
| Methods |
|---|
|
|
|---|
Breeding
We have previously reported on a blood pressure QTL on Chr 1
that included the Sa gene locus.12 This
locus was identified by marker D1M7Mit236 in an
F2 (WKY-1xSHRSP) intercross and was mapped to a
chromosomal region flanked by markers D1 Mit2 and
Mt1pa (Figure 1). The SHRSP
blood pressure allele between Mt1pa and D1
Mit2 was transferred onto the WKY-1 background by 8 successive
backcrosses starting from F1 animals. This was
accomplished by breeding a male SHRSP with a female WKY-1. Each
subsequent backcross was performed by mating male rats that have
genotypically been confirmed to be heterozygous for the SHRSP-Mt1pa/D1
Mit2 allele with female WKY-1 rats. The identification of breeder
animals within each backcross generation was accomplished by analyzing
multiple simple-sequence length polymorphisms (SSLP) within the
region of interest, including markers exceeding the 100:1 odds support
interval for the localization of the QTL on either side (Figure 1). Before homozygous animals were bred, female rats that were
heterozygous for the Chr 1 QTL were mated with male WKY-1 animals. Male
littermates again were mated with WKY-1 female rats, and their
offspring was brotherxsister mated to produce homozygous
WKY-1.SHRSP-Mt1pa/D1 Mit2 congenic animals. This breeding scheme
ensured that, on average, >99.8% of the background genome that
included both gender chromosomes were derived from the WKY-1 recipient.
Congenic sublines were established by mating heterozygous
WKY-1.SHRSP-Mt1pa/D1 Mit2 with WKY-1, the offspring was
genotyped to identify recombinations with the use of
SSLP markers. Appropriate animals were subsequently bred to
homozygosity. This led to the establishment of the congenic subline
WKY-1.SHRSP-Mt1pa/D1Rat57.
|
Blood Pressure Measurements
For all experiments a radiotelemetric method (Data Sciences
International), which allows highly accurate and reproducible blood
pressure determinations, was used as previously reported17
to characterize WKY-1 progenitor and congenic animals. Animals were
operated under anesthesia at 12 weeks of age and were
allowed to recover for 14 days. Hemodynamic
measurements were performed from week 14 to week 16 after birth at
baseline and during the following 12 days of dietary sodium loading
(1% NaCl in drinking water with free access).
Genotype Determination
DNA was extracted according standard procedures from tail tips.
SSLP were obtained from a panel we used previously18 19 ;
additional oligonucleotide sequences for
published microsatellites were obtained from public databases
(http://www.genome.wi.mit.edu/rat/public or
http://www.well.ox.ac.uk/~bihoreau/). PCR was performed on 50 ng of
genomic DNA in a final volume of 10 µL, which contained 100 nmol/L of
each primer, 200 µmol/L dNTPs, 1.5 mmol/L
MgCl2, 50 mmol/L KCl, 10 mmol/L
Tris-HCl (pH 9.0 at 25°C), 0.1% Triton X-100, and 0.25 U of Taq DNA
Polymerase (Promega). The forward primer was labeled with
[
32P]ATP by T4 polynucleotide
kinase. PCR products were processed and subsequently
analyzed by autoradiography after PAGE as
described.17
Statistical Analysis
Differences in blood pressure between progenitor and
congenic/subcongenic strains were evaluated by ANOVA. Linkage
analysis of Chr 1 and blood pressure in the
F2 (WKY-1xSHRSP) has been
reported12 and was calculated by MAPMAKER/EXP and
MAPMAKER/QTL20 with blood pressure values adjusted to male
levels and the first reciprocal cross.18 All blood
pressure values are expressed as mean±SD.
| Results |
|---|
|
|
|---|
Further genotype analysis with newly available markers for rat Chr 1 was performed in the original WKY-1.SHRSP-Mt1pa/D1 Mit2 congenic strain. The results indicated that this strain inherited a fragment derived from SHRSP that spanned at least the chromosomal segment between markers D1Rat200 and Mt1pa. Genotyping analysis in the subcongenic line confirmed the successful transfer of a subsegment from SHRSP onto the WKY-1 genetic background, which defined WKY-1.SHRSP-Mt1pa/D1Rat57 as a congenic substrain of the WKY-1.SHRSP-Mt1pa/D1Rat200 strain (Figure 1). In the WKY-1.SHRSP-Mt1pa/D1Rat57 congenic substrain, the chromosomal region centromeric from the Sa gene was substituted by WKY-1 parental alleles (Figure 1). SSLP analysis with the use of 73 genetic markers throughout the genome confirmed the congenic status of the animals designated WKY-1.SHRSP-Mt1pa/D1Rat200 and WKY-1.SHRSP-Mt1pa/D1Rat57 (data not shown).
Phenotype Characterization of Congenic Animals
Blood pressures were determined in WKY-1.SHRSP-Mt1pa/D1Rat200 and
WKY-1. Systolic and diastolic blood pressure values
were significantly higher in WKY-1.SHRSP-Mt1pa/D1Rat200 as compared
with WKY-1 at baseline (16 weeks of age, day before NaCl loading was
initiated; P<0.001 and P<0.001, respectively)
and after 12 days of NaCl exposure (P<0.001 and
P<0.001, respectively, Table). The strain differences in
blood pressure persisted consistently over the whole time
period studied (Figure 2A) and mirrored
the punctual observations made at baseline and on day 12 of sodium
exposure. The difference in the increase of blood pressure between the
2 strains after NaCl loading was not statistically significant.
|
|
Phenotype Characterization of Subcongenic Animals
Measurements of the congenic substrain WKY-1.SHRSP-Mt1pa/D1Rat57
and WKY-1 progenitors did not show a difference in either
systolic or diastolic blood pressure at baseline
(P=0.83 and P=0.90, respectively) or after NaCl
loading (P=0.56 and P=0.89, respectively; Table).
No difference in blood pressure was detected at any time point
investigated (Figure 2B). There was a significant but equal
increase in blood pressure in response to NaCl exposure in both
WKY-1.SHRSP-Mt1pa/D1Rat57 and WKY-1, which showed no differences
between strains (Figure 2B, Table).
| Discussion |
|---|
|
|
|---|
The hypothesis that this Chr 1 QTL contains a gene or genes that
influence blood pressure is supported by the isolation of this QTL in
congenic animals. Introgressing a large chromosomal region from SHRSP
into WKY-1 animals resulted in the establishment of the congenic strain
WKY-1.SHRSP-Mt1pa/D1Rat200 (Figure 1). This congenic strain
encompassed a region of Chr 1 that exceeded the 100:1 odds support
interval for the initial localization of this QTL in
F2 (SHRSPxWKY-1) animals and spanned the
Sa gene locus. The increase in blood pressure of
10
mm Hg in WKY-1.SHRSP-Mt1pa/D1Rat200 congenic animals compared with
WKY-1 progenitors is in agreement with recent reports on blood pressure
effects in Chr 1 congenic strains with SHR and WKY or Brown Norway rats
as model strains.13 14 15 A more pronounced blood
pressure response after NaCl loading in congenic
WKY-1.SHRSP-Mt1pa/D1Rat200 compared with WKY-1 reference animals,
although theoretically expected from data obtained in the
F2 (WKY-1xSHRSP) cross,12 was
absent, which suggested a less marked phenotypic effect of this QTL on
the NaCl-induced blood pressure in the absence of overall higher blood
pressure attributed to many QTLs in the F2
cohort. The overall effect of this blood pressure QTL accounted for
40% of the blood pressure variance observed after NaCl loading in
the F2 (WKY-1xSHRSP) cross.
The relevance of the Sa gene as a candidate for blood pressure variation was further investigated by initiating congenic substitution mapping approaches. Our study was designed to differentiate between blood pressure effects of the Sa gene locus and the genetic marker D1M7Mit236, which gave rise to the maximal LOD score in our F2 (SHRSPxWKY-1) cohort (Figure 1) detecting the QTL. We identified a recombinant congenic substrain that carried SHRSP alleles defined by markers Mt1pa and D1Rat57 and exhibited wild-type alleles centromeric from marker D1Rat57 (Figure 1). The fact that there was no detectable blood pressure effect in the congenic substrain WKY-1.SHRSP-Mt1pa/D1Rat57 compared with the WKY-1 progenitor strain rules out the Sa gene as a positional candidate for hypertension. Therefore, the QTL is localized centromeric with reference to the Sa gene locus (Figure 1), possibly between markers D1Rat57 and marker D1 Mit2 although the centromeric confines of the transferred SHRSP alleles are likely to exceed the latter. These data are in agreement with the maximum placement of this QTL in our F2 (WKY-1xSHRSP) intercross that is 3.8 cM centromeric to the Sa gene locus (Figure 1) at marker D1M7Mit236.
Our data rule out 2 additional genes, the ß- and
-subunits of the epithelial sodium channel
(Scnn1b and Scnn1g, respectively) as positional
candidates that represent this Chr 1 QTL. Mutations in these
genes have been identified in patients with Liddle's syndrome, which
leads to the formation of constitutively activated epithelial
sodium channels thus increasing renal sodium reabsorption and causing
hypertension.21 22
Moreover, Scnn1b and Scnn1g have recently been implicated in possibly playing a role as basic mechanotransducers in baroreceptor nerve terminals.23 Both genes were previously shown to be closely linked to the Sa gene locus, just on the border of the 100:1 odds support interval of this blood pressure QTL (Figure 1).12 Although earlier investigations could not reveal any relevant coding sequence mutations in different models of genetic hypertension, more subtle mutations, eg, in regulatory elements, could not be excluded in these studies.12 The choice to use WKY-1 as the recipient strain for constructing Chr 1 congenic lines stems from our observation that the Chr 1 QTL exhibits a significant blood pressure effect only in F2 (WKY-1xSHRSP) animals12 but not in the F2 (WKYxSHRSP) cohort24 according to stringent statistical criteria.25
The Chr 1 blood pressure QTL has been confined to a region centromeric of the Sa gene locus. In contrast to the adjacent region telomeric of the Sa gene (11p15.5), this region is syntenic to human chromosome 11p15.4-p15.3, which has not previously been investigated in human hypertension. This provides a possible explanation why the findings on rat Chr 1 could only partly be corroborated in human hypertension thus leading to conflicting results.26 27 28 30 31
The present data warrant a note of caution on potential pitfalls of focusing on candidate genes at early stages in the analysis of complex disease phenotypes. Although the Sa gene exemplifies a prime candidate gene because of its cosegregation with the disease phenotype, expression in the kidney, and differential expression pattern between hypertensive and normotensive parental strains, it should be observed as a marker in linkage studies. Only after a more rigorous approach, such as congenic experimentation and confinement to a small chromosomal region, can a candidate gene be viewed seriously as a bona fide candidate gene.
Given the marked consistency of the effect of this Chr 1
QTL on blood pressure variation of
10 mm Hg within our and
several other congenic strains,13 14 15 it should be
emphasized that results from congenic experimentation with the use of
different parental strains might be integrated. If indeed the same QTL
alleles are operative in different strains, this would
significantly advance the fine mapping of the QTL locus by comparing
blood pressure effects and genetic breakpoints within several
congenic/subcongenic strains.
Despite major successes in QTL detection, fine mapping has been difficult to achieve. This difficulty is presently a major obstacle to both positional cloning and positional candidate gene identification. Further work on the establishment of additional congenic lines that carry smaller subfractions of the Chr 1 blood pressure QTL defined in this study will facilitate both goals.
| Acknowledgments |
|---|
Received March 1, 1999; first decision April 1, 1999; accepted June 9, 1999.
| References |
|---|
|
|
|---|
2. Lifton RP. Molecular genetics of human blood pressure variation. Science.. 1996;272:676680.[Abstract]
3.
Iwai N, Inagami T. Isolation of preferentially
expressed genes in the kidneys of hypertensive rats.
Hypertension.. 1991;17:161169.
4. Patel HR, Thiara AS, West KP, Lodwick D, Samani NJ. Increased expression of the Sa gene in the kidney of the spontaneously hypertensive rat is localized to the proximal tubule. J Hypertens.. 1994;12:13471352.[Medline] [Order article via Infotrieve]
5. Iwai N, Inagami T. Identification of a candidate gene responsible for the high blood pressure of spontaneously hypertensive rats. J Hypertens.. 1992;10:11551157.[Medline] [Order article via Infotrieve]
6. Iwai N, Kurtz TW, Inagami T. Further evidence of the Sa gene as a candidate gene contributing to the hypertension in spontaneously hypertensive rat. Biochem Biophys Res Commun.. 1992;188:6469.[Medline] [Order article via Infotrieve]
7. Samani NJ, Lodwick D, Vincent M, Dubay C, Kaiser MA, Kelly MP, Lo M, Harris J, Sassard J, Lathrop M, Swales JD. A gene differentially expressed in the kidney of the spontaneously hypertensive rat cosegregates with increased blood pressure. J Clin Invest.. 1993;92:10991103.
8. Harris EL, Dene H, Rapp JP. Sa gene and blood pressure cosegregation using Dahl salt-sensitive rats. Am J Hypertens.. 1993;6:330334.[Medline] [Order article via Infotrieve]
9. Nara Y, Nabika,T, Ikeda K, Sawamura M, Mano M, Endo J, Yamori Y. Basal high blood pressure co-segregates with the loci in chromosome 1 in the F2 generation from crosses between normotensive Wistar Kyoto rats and stroke-prone spontaneously hypertensive rats. Biochem Biophys Res Commun.. 1993;194:13441351.[Medline] [Order article via Infotrieve]
10. Brown DM, Provoost AP, Daly MJ, Lander ES, Jacob HJ. Renal disease susceptibility and hypertension are under independent genetic control in the fawn-hooded rat. Nat Genet.. 1996;12:4451.[Medline] [Order article via Infotrieve]
11. Gu L, Dene H, Deng AY, Hoebee B, Bihoreau M-T, James M, Rapp JP. Genetic mapping of two blood pressure quantitative trait loci on rat chromosome 1. J Clin Invest.. 1996;97:777788.[Medline] [Order article via Infotrieve]
12.
Kreutz R, Struk B, Rubattu S, Hübner N, Szpirer
J, Szpirer C, Ganten D, Lindpaintner K. Role of the
-, ß-,
and
-subunit of epithelial sodium channel in a model of polygenic
hypertension. Hypertension.. 1997;29:131136.
13.
St Lezin E, Liu W, Wang J-M, Wang N, Kren V, Krenova D,
Musilova A, Zdobinska M, Zidek V, Lau D, Pravenec M. Genetic isolation
of a chromosome 1 region affecting blood pressure in the spontaneously
hypertensive rat. Hypertension.. 1997;30:854859.
14.
Iwai N, Tsujita Y, Kinoshita M. Isolation of a
chromosome 1 region that contributes to high blood pressure and salt
sensitivity. Hypertension.. 1998;32:636638.
15.
Frantz SA, Kaiser M, Gardiner SM, Gaugier D, Vincent M,
Thompson JR, Bennet T, Samani NJ. Successful isolation of a rat
chromosome 1 blood pressure quantitative trait locus in reciprocal
congenic strains. Hypertension.. 1998;32:639646.
16. Julier C, Delephine M, Keavney B, Terwilliger J, Davis D, Weeks DE, Bui T, Jeunemaitre X, Velho G, Froguel P, Ratcliffe P, Corvol P, Soubrier F, Lathrop GM. Genetic susceptibility for familial essential hypertension in a region of homology with blood pressure linkage on rat chromosome 10. Hum Mol Genet.. 1997;12:20772085.
17.
Kreutz R, Hübner N, James MR, Bihoreau M-T,
Gaugier D, Lathrop GM, Ganten D, Lindpaintner K. Dissection of a
quantitative trait locus for genetic hypertension on rat chromosome 10.
Proc Natl Acad Sci U S A.. 1995;92:87788782.
18. Hilbert P, Lindpaintner K, Beckmann JS, Serikawa T, Soubrier F, Dubay C, Cartwright P, DeGouyon B, Julier C, Takahasi S, Vincent M, Ganten D, Georges M, Lathrop GM. Chromosomal mapping of two genetic loci associated with blood-pressure regulation in hereditary hypertensive rats. Nature.. 1991;353:521529.[Medline] [Order article via Infotrieve]
19. Serikawa T, Kuramoto T, Hilbert P, Mori M, Yamada J, Dubay C, Lindpaintner K, Ganten D, Guenet J, Lathrop GM, Beckmann JS. Rat gene mapping using PCR-analyzed microsatellites. Genetics. 1992;131:703723.
20. Lander ES, Green P, Abrahamson J, Barlow H, Daly MJ, Lincoln SE, Newburg L. MAPMAKER: an interactive computer package for constructing primary genetic linkage maps of experimental and natural populations. Genomics.. 1987;1:174181.[Medline] [Order article via Infotrieve]
21. Shimkets RA, Warnock DG, Bositis CM, Nelson-Williams C, Hansson JH, Schambelan M, Gill JR, Ulick S, Milora RV, Findling JW, Canessa CM, Rossier BC, Lifton RP. Liddle's Syndrome: heritable human hypertension caused by mutations in the beta subunit of the epithelial sodium channel. Cell.. 1994;79:407414.[Medline] [Order article via Infotrieve]
22. Hansson JH, Nelson-Williams C, Suzuki H, Schild L, Shimkets R, Lu Y, Canessa C, Iwasaki T, Rossier B, Lifton RP. Hypertension caused by a truncated epithelial sodium channel gamma subunit: genetic heterogeneity of Liddle's syndrome. Nat Genet.. 1995;11:7682.[Medline] [Order article via Infotrieve]
23. Drummond HA, Price MP, Welsh MJ, Abboud FM. A molecular component of the arterial baroreceptor mechanotransducer. Neuron.. 1998;21:14351441.[Medline] [Order article via Infotrieve]
24. Lindpaintner K, Hilbert P, Ganten D, Nadal-Ginard B, Inagami T, Iwai N. Molecular genetics of the Sa-gene: cosegregation with hypertension and mapping to rat chromosome 1. J Hypertens.. 1993;11:1923.[Medline] [Order article via Infotrieve]
25. Lander E, Kruglyak L. Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat Genet.. 1995;11:241247.[Medline] [Order article via Infotrieve]
26.
Iwai N, Ohmici N, Hanai K, Nakamura Y, Kinoshita M.
Human Sa gene locus as a candidate locus for essential
hypertension. Hypertension.. 1994;23:375380.
27.
Nabika T, Bonnardeaux A, James M, Julier C, Jeunemaitre
X, Corvol P, Lathrop M, Soubrier F. Evaluation of the Sa
locus in human hypertension. Hypertension.. 1995;25:613.
28. Zee RY, Stephen AL, Iwai N, Morris BJ. Association of Sa gene variant in essential hypertensives. Am J Hypertens. 1997;10:235242.[Medline] [Order article via Infotrieve]
29. Levan G, Hedrich HJ, Remmers EF, Serikawa T, Yoshida MC. Standardized rat genetic nomenclature. Mamm Genome.. 1995;6:447448.[Medline] [Order article via Infotrieve]
30.
Wong ZYH, Stebbing M, Ellis JA, Lamantia A, Harrap SB.
Genetic linkage of ß and
subunits of epithelial sodium
channel to systolic blood pressure. Lancet.. 1999;353:12221225.[Medline]
[Order article via Infotrieve]
31. Colhoun H. Confirmation needed for hypertension genes. Lancet.. 1999;353:12001201.[Medline] [Order article via Infotrieve]
This article has been cited by other articles:
![]() |
R. I. Dmitrieva, C. A. Hinojos, M. L. Grove, R. J. Bell, E. Boerwinkle, M. Fornage, and P. A. Doris Genome-Wide Identification of Allelic Expression in Hypertensive Rats Circ Cardiovasc Genet, April 1, 2009; 2(2): 106 - 115. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Kota, H. Schulz, S. Falak, N. Hubner, and M. Osborne-Pellegrin Localization of genetic loci controlling hydronephrosis in the Brown Norway rat and its association with hematuria Physiol Genomics, July 1, 2008; 34(2): 215 - 224. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Y. Deng Genetic basis of polygenic hypertension Hum. Mol. Genet., October 15, 2007; 16(R2): R195 - R202. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Y. Woon, P. J. Kaisaki, J. Braganca, M.-T. Bihoreau, J. C. Levy, M. Farrall, and D. Gauguier Aryl hydrocarbon receptor nuclear translocator-like (BMAL1) is associated with susceptibility to hypertension and type 2 diabetes PNAS, September 4, 2007; 104(36): 14412 - 14417. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Kota, M. Osborne-Pellegrin, H. Schulz, J. Behmoaras, M. Coutard, M. Gong, and N. Hubner Quantitative genetic basis of arterial phenotypes in the Brown Norway rat Physiol Genomics, June 19, 2007; 30(1): 17 - 25. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Y. Deng Positional Cloning of Quantitative Trait Loci for Blood Pressure: How Close Are We?: A Critical Perspective Hypertension, April 1, 2007; 49(4): 740 - 747. [Full Text] [PDF] |
||||
![]() |
B. Joe, N. E. Letwin, M. R. Garrett, S. Dhindaw, B. Frank, R. Sultana, K. Verratti, J. P. Rapp, and N. H. Lee Transcriptional profiling with a blood pressure QTL interval-specific oligonucleotide array Physiol Genomics, November 17, 2005; 23(3): 318 - 326. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Hinojos, E. Boerwinkle, M. Fornage, and P. A. Doris Combined Genealogical, Mapping, and Expression Approaches to Identify Spontaneously Hypertensive Rat Hypertension Candidate Genes Hypertension, April 1, 2005; 45(4): 698 - 704. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Garrett, H. Meng, J. P. Rapp, and B. Joe Locating a Blood Pressure Quantitative Trait Locus Within 117 kb on the Rat Genome: Substitution Mapping and Renal Expression Analysis Hypertension, March 1, 2005; 45(3): 451 - 459. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Areste, M J. Melia, J. Isern, J. L. Tovar, and A. Meseguer Sex steroid regulation and identification of different transcription units of the SA gene in mouse kidney J. Endocrinol., October 1, 2004; 183(1): 101 - 114. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Mein, M. J. Caulfield, R. J. Dobson, and P. B. Munroe Genetics of essential hypertension Hum. Mol. Genet., April 1, 2004; 13(90001): R169 - 175. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Kato, T. Nabika, Y.-Q. Liang, T. Mashimo, H. Inomata, T. Watanabe, K. Yanai, Y. Yamori, Y. Yazaki, and T. Sasazuki Isolation of a Chromosome 1 Region Affecting Blood Pressure and Vascular Disease Traits in the Stroke-Prone Rat Model Hypertension, December 1, 2003; 42(6): 1191 - 1197. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Walsh, L. Somody, A. Farrell, B. Zhang, J. Brown, C. Pritchard, M. Vincent, and N. J. Samani Analysis of the Role of the SA Gene in Blood Pressure Regulation by Gene Targeting Hypertension, June 1, 2003; 41(6): 1212 - 1218. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Iwai, T. Mannami, H. Tomoike, K. Ono, and Y. Iwanaga An Acyl-CoA Synthetase Gene Family in Chromosome 16p12 May Contribute to Multiple Risk Factors Hypertension, May 1, 2003; 41(5): 1041 - 1046. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Monti, H. Zimdahl, H. Schulz, R. Plehm, D. Ganten, and N. Hubner The Role of Wnk4 in Polygenic Hypertension: A Candidate Gene Analysis on Rat Chromosome 10 Hypertension, April 1, 2003; 41(4): 938 - 942. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Monti, R. Plehm, H. Schulz, D. Ganten, R. Kreutz, and N. Hubner Interaction between blood pressure quantitative trait loci in rats in which trait variation at chromosome 1 is conditional upon a specific allele at chromosome 10 Hum. Mol. Genet., February 15, 2003; 12(4): 435 - 439. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Pravenec, C. Wallace, T. J. Aitman, and T. W. Kurtz Gene Expression Profiling in Hypertension Research: A Critical Perspective Hypertension, January 1, 2003; 41(1): 3 - 8. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Frantz, J.-R. Clemitson, M.-T. Bihoreau, D. Gauguier, and N. J. Samani Genetic Dissection of Region Around the Sa Gene on Rat Chromosome 1: Evidence for Multiple Loci Affecting Blood Pressure Hypertension, August 1, 2001; 38(2): 216 - 221. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Gumprecht, M. J. Zychma, W. Grzeszczak, and E. Zukowska-Szczechowska Human SA gene Pst1 polymorphism and chronic renal failure: Results of the family-based study Nephrol. Dial. Transplant., February 1, 2001; 16(2): 387 - 390. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. SAAD, M. R. GARRETT, and J. P. RAPP Multiple blood pressure QTL on rat chromosome 1 defined by Dahl rat congenic strains Physiol Genomics, January 19, 2001; 4(3): 201 - 214. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. St. Lezin, W. Liu, J.-M. Wang, Y. Yang, N. Qi, V. Kren, V. Zidek, T. W. Kurtz, and M. Pravenec Genetic Analysis of Rat Chromosome 1 and the Sa Gene in Spontaneous Hypertension Hypertension, January 1, 2000; 35(1): 225 - 230. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Fujino, Y. A. Takei, H. Sone, R. X. Ioka, A. Kamataki, K. Magoori, S. Takahashi, J. Sakai, and T. T. Yamamoto Molecular Identification and Characterization of Two Medium-chain Acyl-CoA Synthetases, MACS1 and the Sa Gene Product J. Biol. Chem., September 14, 2001; 276(38): 35961 - 35966. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Liang, B. Yuan, E. Rute, A. S. Greene, A.-P. Zou, P. Soares, G. D. MCQuestion, G. R. Slocum, H. J. Jacob, and A. W. Cowley Jr. Renal medullary genes in salt-sensitive hypertension: a chromosomal substitution and cDNA microarray study Physiol Genomics, February 28, 2002; 8(2): 139 - 149. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1999 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |